A Phase II Study of Celecoxib/Oxaliplatin/Capecitabine Combination Chemotherapy for Unresectable,Recurrent, or Metastatic Gastric/Gastroesophageal Junction Carcinoma
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Capecitabine; Celecoxib; Oxaliplatin
- Indications Gastric cancer
- Focus Therapeutic Use
- 08 Feb 2019 Biomarkers information updated
- 07 Dec 2007 Status changed from in progress to completed as reported by ClinicalTrials.gov.
- 09 Jan 2007 Status change